期刊
BRAIN STIMULATION
卷 10, 期 2, 页码 260-262出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.brs.2016.11.005
关键词
Major depressive disorder; Bipolar disorder; Treatment-emergent mania; Manic switch; Transcranial direct current stimulation
资金
- NARSAD Young Investigator from the Brain & Behavior Research Foundation [20493]
- FAPESP Young Researcher from the Sao Paulo State Foundation [20911-5]
- National Council for Scientific and Technological Development (CNPq) [470904]
- CNPq [303197]
- Australian National Health and Medical Research Council [510142]
- Stanley Medical Research Foundation [11T-005]
- International Postgraduate Research Scholarship (UNSW)
- Pedro I Pons Research Scholarship (University of Barcelona)
Background: Treatment-emergent mania/hypomania (TEM) is a possible adverse effect of pharmacological and non-pharmacological antidepressant treatments. Objective: We performed a systematic review and meta-analysis to evaluate the risk of TEM in depressed patients during randomized, sham-controlled trials (RCTs). Data sources: Medline database, from the first date available to August 12, 2016. Results: From 283 references, 10 RCTs were identified. Only 3 of them described TEM. In active and sham groups, respectively, only 8 of 226 (3.5%) and 1 of 190 (0.5%) participants presented TEM. This difference was not statistically significant (OR = 1.79, 95% CI = 0.6 to 5.32). There were also five additional reports of TEM in participants not on RCTs. No risk factors for TEM were identified. Limitations: Low number of studies and TEM reports. Conclusion: Despite previous reports, active vs. sham tDCS was not associated with a significantly greater number of TEM episodes. (C) 2016 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据